In HDL particles isolated from women newly diagnosed with breast cancer and control subjects, we investigated three aspects: (1) the composition in lipids and apoA-I; (2) the differential expression of miRs related to inflammation; and (3) the ability to inhibit the inflammatory response in macrophages. This evidence concerns the gene APOA1 and breast carcinoma.